These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21843937)

  • 1. Synthesis and biological evaluation of 4-piperidinecarboxylate and 4-piperidinecyanide derivatives for T-type calcium channel blockers.
    Woo HM; Lee YS; Roh EJ; Seo SH; Song CM; Chung HJ; Pae AN; Shin KJ
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5910-5. PubMed ID: 21843937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of novel T-type Ca2+ channel blockers.
    Jung HK; Doddareddy MR; Cha JH; Rhim H; Cho YS; Koh HY; Jung BY; Pae AN
    Bioorg Med Chem; 2004 Aug; 12(15):3965-70. PubMed ID: 15246072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of alpha,alpha'-disubstituted phenylacetate derivatives for T-type calcium channel blockers.
    Lee HK; Lee YS; Roh EJ; Rhim H; Lee JY; Shin KJ
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4424-7. PubMed ID: 18625556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channels.
    Yang ZQ; Barrow JC; Shipe WD; Schlegel KA; Shu Y; Yang FV; Lindsley CW; Rittle KE; Bock MG; Hartman GD; Uebele VN; Nuss CE; Fox SV; Kraus RL; Doran SM; Connolly TM; Tang C; Ballard JE; Kuo Y; Adarayan ED; Prueksaritanont T; Zrada MM; Marino MJ; Graufelds VK; DiLella AG; Reynolds IJ; Vargas HM; Bunting PB; Woltmann RF; Magee MM; Koblan KS; Renger JJ
    J Med Chem; 2008 Oct; 51(20):6471-7. PubMed ID: 18817368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel T-type calcium channel blockers: dioxoquinazoline carboxamide derivatives.
    Jo MN; Seo HJ; Kim Y; Seo SH; Rhim H; Cho YS; Cha JH; Koh HY; Choo H; Pae AN
    Bioorg Med Chem; 2007 Jan; 15(1):365-73. PubMed ID: 17035033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and SAR studies of a novel series of T-type calcium channel blockers.
    Park SJ; Park SJ; Lee MJ; Rhim H; Kim Y; Lee JH; Chung BY; Lee JY
    Bioorg Med Chem; 2006 May; 14(10):3502-11. PubMed ID: 16434203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3,4-Dihydroquinazoline derivatives as novel selective T-type Ca2+ channel blockers.
    Lee YS; Lee BH; Park SJ; Kang SB; Rhim H; Park JY; Lee JH; Jeong SW; Lee JY
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3379-84. PubMed ID: 15177437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of T-type calcium channel in the development of neuropathic pain following chronic compression of rat dorsal root ganglia.
    Wen XJ; Xu SY; Chen ZX; Yang CX; Liang H; Li H
    Pharmacology; 2010; 85(5):295-300. PubMed ID: 20453553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and evaluation of a novel 4-aminomethyl-4-fluoropiperidine as a T-type Ca2+ channel antagonist.
    Shipe WD; Barrow JC; Yang ZQ; Lindsley CW; Yang FV; Schlegel KA; Shu Y; Rittle KE; Bock MG; Hartman GD; Tang C; Ballard JE; Kuo Y; Adarayan ED; Prueksaritanont T; Zrada MM; Uebele VN; Nuss CE; Connolly TM; Doran SM; Fox SV; Kraus RL; Marino MJ; Graufelds VK; Vargas HM; Bunting PB; Hasbun-Manning M; Evans RM; Koblan KS; Renger JJ
    J Med Chem; 2008 Jul; 51(13):3692-5. PubMed ID: 18540666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of trimethoxybenzyl piperazine N-type calcium channel inhibitors.
    Pajouhesh H; Feng ZP; Zhang L; Pajouhesh H; Jiang X; Hendricson A; Dong H; Tringham E; Ding Y; Vanderah TW; Porreca F; Belardetti F; Zamponi GW; Mitscher LA; Snutch TP
    Bioorg Med Chem Lett; 2012 Jun; 22(12):4153-8. PubMed ID: 22579422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of 1-(isoxazol-5-ylmethylaminoethyl)-4-phenyl tetrahydropyridine and piperidine derivatives as potent T-type calcium channel blockers with antinociceptive effect in a neuropathic pain model.
    Lee JH; Seo SH; Lim EJ; Cho NC; Nam G; Kang SB; Pae AN; Jeong N; Keum G
    Eur J Med Chem; 2014 Mar; 74():246-57. PubMed ID: 24480356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of oxazole derivatives as T-type calcium channel blockers.
    Lee JE; Koh HY; Seo SH; Baek YY; Rhim H; Cho YS; Choo H; Pae AN
    Bioorg Med Chem Lett; 2010 Jul; 20(14):4219-22. PubMed ID: 20621730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and T-type calcium channel-blocking effects of aryl(1,5-disubstituted-pyrazol-3-yl)methyl sulfonamides for neuropathic pain treatment.
    Kim JH; Keum G; Chung H; Nam G
    Eur J Med Chem; 2016 Nov; 123():665-672. PubMed ID: 27517811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of 1-(2-hydroxy-3-phenyloxypropyl)piperazine derivatives as T-type calcium channel blockers.
    Park JE; Ji WK; Jang JW; Pae AN; Choi K; Choi KH; Kang J; Roh EJ
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1887-90. PubMed ID: 23395659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lead discovery and optimization of T-type calcium channel blockers.
    Park JH; Choi JK; Lee E; Lee JK; Rhim H; Seo SH; Kim Y; Doddareddy MR; Pae AN; Kang J; Roh EJ
    Bioorg Med Chem; 2007 Feb; 15(3):1409-19. PubMed ID: 17150365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scaffold-based design and synthesis of potent N-type calcium channel blockers.
    Zamponi GW; Feng ZP; Zhang L; Pajouhesh H; Ding Y; Belardetti F; Pajouhesh H; Dolphin D; Mitscher LA; Snutch TP
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6467-72. PubMed ID: 19815411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of pyrrolidine-based T-type calcium channel inhibitors for the treatment of neuropathic pain.
    Yang HK; Son WS; Lim KS; Kim GH; Lim EJ; Gadhe CG; Lee JY; Jeong KS; Lim SM; Pae AN
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1460-1471. PubMed ID: 30231778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-type calcium channel blockers: spiro-piperidine azetidines and azetidinones-optimization, design and synthesis.
    Smith EM; Sorota S; Kim HM; McKittrick BA; Nechuta TL; Bennett C; Knutson C; Burnett DA; Kieselgof J; Tan Z; Rindgen D; Bridal T; Zhou X; Jia YP; Dong Z; Mullins D; Zhang X; Priestley T; Correll CC; Tulshian D; Czarniecki M; Greenlee WJ
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4602-6. PubMed ID: 20580233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel tetrahydroisoquinoline derivatives as orally active N-type calcium channel blockers with high selectivity for hERG potassium channels.
    Ogiyama T; Inoue M; Honda S; Yamada H; Watanabe T; Gotoh T; Kiso T; Koakutsu A; Kakimoto S; Shishikura J
    Bioorg Med Chem; 2014 Dec; 22(24):6899-907. PubMed ID: 25456079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facile synthesis and biological evaluation of 3,3-diphenylpropanoyl piperazines as T-type calcium channel blockers.
    Choi YH; Baek du J; Seo SH; Lee JK; Pae AN; Cho YS; Min SJ
    Bioorg Med Chem Lett; 2011 Jan; 21(1):215-9. PubMed ID: 21126876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.